These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4650666)

  • 1. The evaluation of guingestanol acetate as a low dose oral contraceptive.
    Maqueo M; Mischler TW; Berman E
    Contraception; 1972 Aug; 6(2):117-25. PubMed ID: 4650666
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous microdose (0.3 mg) quingestanol acetate as an oral contraceptive agent.
    Jubhari S; Lane ME; Sobrero AJ
    Contraception; 1974 Mar; 9(3):213-9. PubMed ID: 4613533
    [No Abstract]   [Full Text] [Related]  

  • 3. Further experience with quingestanol acetate as a postcoital oral contraceptive.
    Mischler TW; Rubio B; Larranaga A; Guiloff E; Moggia AV
    Contraception; 1974 Mar; 9(3):221-5. PubMed ID: 4613534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amenorrhea, anovulation and oligomenorrhea due to use of oral contraceptives].
    James M; Rozenbaum H
    Concours Med; 1974 Mar; 96(10):1559-60, 1563-4, 1567-8. PubMed ID: 4619979
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily megestrol acetate for fertility control: a clinical study.
    Casavilla F; Stubrin J; Maruffo C; van Nynatten B; Perez V
    Contraception; 1972 Nov; 6(5):361-72. PubMed ID: 4663178
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.
    Brache V; Sitruk-Ware R; Williams A; Blithe D; Croxatto H; Kumar N; Kumar S; Tsong YY; Sivin I; Nath A; Sussman H; Cochon L; Miranda MJ; Reyes V; Faundes A; Mishell D
    Contraception; 2012 May; 85(5):480-8. PubMed ID: 22176795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of progestogens as postcoital oral contraceptives.
    Moggia A; Beauquis A; Ferrari F; Torrado ML; Alonso JL; Koremblit E; Mischler T
    J Reprod Med; 1974 Aug; 13(2):58-61. PubMed ID: 4844514
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the contraceptive efficacy of Quingestanol acetate in daily microdose and post coitum.
    Moggia A; Mischler T; Beauquis A; Zarate J; Torrado M; Ferrari F; Koremblit E
    J Reprod Med; 1973 Apr; 10(4):186-92. PubMed ID: 4735194
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience in india with a once-a-month oral contraceptive pill: qingestanol and quinestrol.
    Tejuja S; Choudhury AD; Saxena NC; Malhotra U; Bhinder G
    Contraception; 1974 Oct; 10(4):375-83. PubMed ID: 4448057
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervals.
    Mora G; Faundes A; Pastore U
    Contraception; 1974 Aug; 10(2):145-57. PubMed ID: 4421020
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the contraceptive efficacy of quingestanol acetate (W 4540) when administered as an oral low-dose conraceptive in the puerperium.
    Moggia AV; Mischler T; Berman E; Beauquis A; Torrrado M; Koremblitt E
    J Reprod Med; 1972 Apr; 8(4):169-73. PubMed ID: 4555282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate.
    Jesam C; Cochon L; Salvatierra AM; Williams A; Kapp N; Levy-Gompel D; Brache V
    Contraception; 2016 Apr; 93(4):310-316. PubMed ID: 26764121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further experience with a once-a-month oral contraceptive: quinestrol-quingestanol.
    Rubio B; Mischler TW; Berman E
    Fertil Steril; 1972 Oct; 23(10):734-8. PubMed ID: 4651624
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term use of depot medroxy progesterone acetate as a contraceptive.
    el-Mahgoub S; Karim M; Ammar R
    Acta Obstet Gynecol Scand; 1972; 51(3):251-5. PubMed ID: 5072160
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
    Jeppsson S
    Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
    Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
    Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical use of me-quingestanol contraceptive pill (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979 Apr; 14(2):68-72. PubMed ID: 263035
    [No Abstract]   [Full Text] [Related]  

  • 18. Fertility following termination of the once-a-month oral contraceptive.
    Maqueo-Topete M; Mischler TW
    Contraception; 1974 Sep; 10(3):299-304. PubMed ID: 4442272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.
    Gardner JM; Mishell DR
    Fertil Steril; 1970 Apr; 21(4):286-91. PubMed ID: 5508497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.